The active healthcare ETF TMED, managed by T. Rowe Price, has delivered a strong 20.56% return over the past year, significantly beating its benchmark, the S&P Health Care Select Sector Index, which returned 11.1%. TMED invests in a diversified mix of U.S. and international healthcare stocks, including biotech, pharmaceuticals, and healthcare services, using a fundamental, bottom-up research approach. This performance highlights healthcare stocks' defensive appeal amid global uncertainties and high valuations in tech sectors, making TMED an attractive option for investors seeking growth with reduced risk exposure. The ETF charges a competitive 44 basis point fee and could play a key role in portfolios facing geopolitical and economic challenges in 2026.
